303 related articles for article (PubMed ID: 30082493)
1. Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?
Natkunam Y; Gratzinger D; Chadburn A; Goodlad JR; Chan JKC; Said J; Jaffe ES; de Jong D
Blood; 2018 Nov; 132(18):1871-1878. PubMed ID: 30082493
[TBL] [Abstract][Full Text] [Related]
2. Immunodeficiency-associated lymphoid proliferations (ALPS, HIV, and KSHV/HHV8).
Chadburn A
Semin Diagn Pathol; 2013 May; 30(2):113-29. PubMed ID: 23537912
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis and management of EBV-positive lymphoproliferative disorders].
Arai A
Rinsho Ketsueki; 2023; 64(8):764-771. PubMed ID: 37673629
[TBL] [Abstract][Full Text] [Related]
4. Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: a mini review.
Shimoyama Y; Oyama T; Asano N; Oshiro A; Suzuki R; Kagami Y; Morishima Y; Nakamura S
J Clin Exp Hematop; 2006 Mar; 46(1):1-4. PubMed ID: 17058802
[TBL] [Abstract][Full Text] [Related]
5. Lymphoproliferative disorders in children with primary immunodeficiencies: immunological status may be more predictive of the outcome than other criteria.
Canioni D; Jabado N; MacIntyre E; Patey N; Emile JF; Brousse N
Histopathology; 2001 Feb; 38(2):146-59. PubMed ID: 11207828
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological findings, prognosis, and Epstein-Barr virus infection in rheumatoid arthritis patients with other iatrogenic immunodeficiency-associated T- and NK-cell lymphoproliferative disorders.
Kimura S; Oshiro Y; Iwasaki H; Kadowaki M; Ogata M; Daa T; Sakata T; Kawauchi S; Wang Z; Takamatsu Y; Takeshita M
BMC Cancer; 2022 Dec; 22(1):1342. PubMed ID: 36544095
[TBL] [Abstract][Full Text] [Related]
7. Skin-Limited, Methotrexate-Associated Epstein-Barr Virus-Positive Mucocutaneous Ulcer-A Mimicker of High-Grade Lymphoma. A Report of 4 Cases and Review of the Literature.
Macklin PS; Fisher R; Stonard C; Matin RN; Ieremia E
Am J Dermatopathol; 2023 Aug; 45(8):519-531. PubMed ID: 37462204
[TBL] [Abstract][Full Text] [Related]
8. Immunodeficiency-Associated Epstein-Barr Virus-Positive B-cell Lymphoproliferative Disorders: A Review and New Paradigm.
Chapman J
Surg Pathol Clin; 2023 Jun; 16(2):213-231. PubMed ID: 37149357
[TBL] [Abstract][Full Text] [Related]
9. Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases.
Fujimoto K; Hatanaka KC; Hatanaka Y; Kasahara I; Yamamoto S; Tsuji T; Nakata M; Takakuwa Y; Haseyama Y; Oyamada Y; Yonezumi M; Suzuki H; Sakai H; Noguchi H; Mori A; Nishihara H; Teshima T; Matsuno Y
Hematol Oncol; 2020 Dec; 38(5):799-807. PubMed ID: 32798315
[TBL] [Abstract][Full Text] [Related]
10. Anti-CCR4 monoclonal antibody mogamulizumab for the treatment of EBV-associated T- and NK-cell lymphoproliferative diseases.
Kanazawa T; Hiramatsu Y; Iwata S; Siddiquey M; Sato Y; Suzuki M; Ito Y; Goshima F; Murata T; Kimura H
Clin Cancer Res; 2014 Oct; 20(19):5075-84. PubMed ID: 25117294
[TBL] [Abstract][Full Text] [Related]
11. Iatrogenic immunodeficiency-associated lymphoproliferative disorders of B-cell type that develop in patients receiving immunosuppressive drugs other than in the post-transplant setting.
Momose S; Tamaru JI
J Clin Exp Hematop; 2019; 59(2):48-55. PubMed ID: 31257345
[TBL] [Abstract][Full Text] [Related]
12. Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases.
Latour S; Winter S
Front Immunol; 2018; 9():1103. PubMed ID: 29942301
[TBL] [Abstract][Full Text] [Related]
13. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders.
Knowles DM; Cesarman E; Chadburn A; Frizzera G; Chen J; Rose EA; Michler RE
Blood; 1995 Jan; 85(2):552-65. PubMed ID: 7812011
[TBL] [Abstract][Full Text] [Related]
14. [Inherited lymphoproliferative disorders].
Kanegane H; Hoshino A
Rinsho Ketsueki; 2019; 60(6):708-715. PubMed ID: 31281164
[TBL] [Abstract][Full Text] [Related]
15. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.
Ohshima K; Kimura H; Yoshino T; Kim CW; Ko YH; Lee SS; Peh SC; Chan JK;
Pathol Int; 2008 Apr; 58(4):209-17. PubMed ID: 18324913
[TBL] [Abstract][Full Text] [Related]
16. How I Diagnose EBV-Positive B- and T-Cell Lymphoproliferative Disorders.
Dojcinov SD; Quintanilla-Martinez L
Am J Clin Pathol; 2023 Jan; 159(1):14-33. PubMed ID: 36214507
[TBL] [Abstract][Full Text] [Related]
17. Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders with a T- or NK-cell phenotype.
Satou A; Tsuzuki T; Nakamura S
J Clin Exp Hematop; 2019; 59(2):56-63. PubMed ID: 31257346
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.
Cai Q; Chen K; Young KH
Exp Mol Med; 2015 Jan; 47(1):e133. PubMed ID: 25613730
[TBL] [Abstract][Full Text] [Related]
19. [The understanding of Epstein-Barr virus associated lymphoproliferative disorder].
Zhou XG; Zhang YL; Xie JL; Huang YH; Zheng YY; Li WS; Chen H; Liu F; Pan HX; Wei P; Wang Z; Hu YC; Yang KY; Xiao HL; Wu MJ; Yin WH; Mei KY; Chen G; Yan XC; Meng G; Xu G; Li J; Tian SF; Zhu J; Song YQ; Zhang WJ
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):817-821. PubMed ID: 28056294
[TBL] [Abstract][Full Text] [Related]
20. Advances in Understanding the Pathogenesis of Epstein-Barr Virus-Associated Lymphoproliferative Disorders.
Yang X; Nishida N; Zhao X; Kanegane H
Iran J Allergy Asthma Immunol; 2015 Oct; 14(5):462-71. PubMed ID: 26742434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
